Loading…

In vitro and in silico analysis of the effects of D 2 receptor antagonist target binding kinetics on the cellular response to fluctuating dopamine concentrations

Target binding kinetics influence the time course of the drug effect (pharmacodynamics) both (i) directly, by affecting the time course of target occupancy, driven by the pharmacokinetics of the drug, competition with endogenous ligands and target turnover, and (ii) indirectly, by affecting signal t...

Full description

Saved in:
Bibliographic Details
Published in:British journal of pharmacology 2018-11, Vol.175 (21), p.4121-4136
Main Authors: de Witte, Wilhelmus E A, Versfelt, Joost W, Kuzikov, Maria, Rolland, Solene, Georgi, Victoria, Gribbon, Philip, Gul, Sheraz, Huntjens, Dymphy, van der Graaf, Piet Hein, Danhof, Meindert, Fernández-Montalván, Amaury, Witt, Gesa, de Lange, Elizabeth C M
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c1527-56a21eddcfccb0af07b610c9876ea85b60f0761dc0bab3e07973b96cbb6b7f643
cites cdi_FETCH-LOGICAL-c1527-56a21eddcfccb0af07b610c9876ea85b60f0761dc0bab3e07973b96cbb6b7f643
container_end_page 4136
container_issue 21
container_start_page 4121
container_title British journal of pharmacology
container_volume 175
creator de Witte, Wilhelmus E A
Versfelt, Joost W
Kuzikov, Maria
Rolland, Solene
Georgi, Victoria
Gribbon, Philip
Gul, Sheraz
Huntjens, Dymphy
van der Graaf, Piet Hein
Danhof, Meindert
Fernández-Montalván, Amaury
Witt, Gesa
de Lange, Elizabeth C M
description Target binding kinetics influence the time course of the drug effect (pharmacodynamics) both (i) directly, by affecting the time course of target occupancy, driven by the pharmacokinetics of the drug, competition with endogenous ligands and target turnover, and (ii) indirectly, by affecting signal transduction and homeostatic feedback. For dopamine D receptor antagonists, it has been hypothesized that fast receptor binding kinetics cause fewer side effects, because part of the dynamics of the dopaminergic system is preserved by displacement of these antagonists. Target binding kinetics of D receptor antagonists and signal transduction after dopamine and D receptor antagonist exposure were measured in vitro. These data were integrated by mechanistic modelling, taking into account competitive binding of endogenous dopamine and the antagonist, the turnover of the second messenger cAMP and negative feedback by PDE turnover. The proposed signal transduction model successfully described the cellular cAMP response for 17 D receptor antagonists with widely different binding kinetics. Simulation of the response to fluctuating dopamine concentrations revealed that a significant effect of the target binding kinetics on the dynamics of the signalling only occurs at endogenous dopamine concentration fluctuations with frequencies below 1 min . Signal transduction and feedback are important determinants of the time course of drug effects. The effect of the D receptor antagonist dissociation rate constant (k ) is limited to the maximal rate of fluctuations in dopamine signalling as determined by the dopamine k and the cAMP turnover.
doi_str_mv 10.1111/bph.14456
format article
fullrecord <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6177617</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>30051456</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1527-56a21eddcfccb0af07b610c9876ea85b60f0761dc0bab3e07973b96cbb6b7f643</originalsourceid><addsrcrecordid>eNpVkc1OAyEUhYnR2Fpd-AKGrYtR6MzAdGNi6l-TJm50TYCBFqUwAaZJH8c3lbba6N3c3HvPdyA5AFxidINz3YpueYOrqiZHYIgrSoq6bPAxGCKEaIFx0wzAWYwfCOUjrU_BoESoxlk_BF8zB9cmBQ-5a6FxMBpr5HbidhNNhF7DtFRQaa1k2o0PcAyDkqpLPmRd4gvvTEww8bBQCQrjWuMW8NM4lYzMiNs5SGVtb3nIbOy8iwomD7XtZep52gKt7_gqQ1B6J5VLIa-z7hycaG6juvjpI_D-9Pg2fSnmr8-z6f28kLge06ImfIxV20otpUBcIyoIRnLSUKJ4UwuC8orgViLBRakQndBSTIgUggiqSVWOwN3et-vFSrX7H1jWBbPiYcM8N-z_xZklW_g1I5hmY5oNrvcGMvgYg9IHFiO2zYnlnNgup6y9-vvYQfkbTPkNZiaT9w</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>In vitro and in silico analysis of the effects of D 2 receptor antagonist target binding kinetics on the cellular response to fluctuating dopamine concentrations</title><source>PubMed (Medline)</source><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>de Witte, Wilhelmus E A ; Versfelt, Joost W ; Kuzikov, Maria ; Rolland, Solene ; Georgi, Victoria ; Gribbon, Philip ; Gul, Sheraz ; Huntjens, Dymphy ; van der Graaf, Piet Hein ; Danhof, Meindert ; Fernández-Montalván, Amaury ; Witt, Gesa ; de Lange, Elizabeth C M</creator><creatorcontrib>de Witte, Wilhelmus E A ; Versfelt, Joost W ; Kuzikov, Maria ; Rolland, Solene ; Georgi, Victoria ; Gribbon, Philip ; Gul, Sheraz ; Huntjens, Dymphy ; van der Graaf, Piet Hein ; Danhof, Meindert ; Fernández-Montalván, Amaury ; Witt, Gesa ; de Lange, Elizabeth C M</creatorcontrib><description>Target binding kinetics influence the time course of the drug effect (pharmacodynamics) both (i) directly, by affecting the time course of target occupancy, driven by the pharmacokinetics of the drug, competition with endogenous ligands and target turnover, and (ii) indirectly, by affecting signal transduction and homeostatic feedback. For dopamine D receptor antagonists, it has been hypothesized that fast receptor binding kinetics cause fewer side effects, because part of the dynamics of the dopaminergic system is preserved by displacement of these antagonists. Target binding kinetics of D receptor antagonists and signal transduction after dopamine and D receptor antagonist exposure were measured in vitro. These data were integrated by mechanistic modelling, taking into account competitive binding of endogenous dopamine and the antagonist, the turnover of the second messenger cAMP and negative feedback by PDE turnover. The proposed signal transduction model successfully described the cellular cAMP response for 17 D receptor antagonists with widely different binding kinetics. Simulation of the response to fluctuating dopamine concentrations revealed that a significant effect of the target binding kinetics on the dynamics of the signalling only occurs at endogenous dopamine concentration fluctuations with frequencies below 1 min . Signal transduction and feedback are important determinants of the time course of drug effects. The effect of the D receptor antagonist dissociation rate constant (k ) is limited to the maximal rate of fluctuations in dopamine signalling as determined by the dopamine k and the cAMP turnover.</description><identifier>ISSN: 0007-1188</identifier><identifier>EISSN: 1476-5381</identifier><identifier>DOI: 10.1111/bph.14456</identifier><identifier>PMID: 30051456</identifier><language>eng</language><publisher>England: John Wiley and Sons Inc</publisher><subject>Animals ; Binding Sites - drug effects ; CHO Cells ; Cricetulus ; Dopamine - pharmacology ; Dopamine Antagonists - pharmacology ; Kinetics ; Models, Biological ; Receptors, Dopamine D2 - metabolism ; Research Paper ; Research Papers ; Signal Transduction - drug effects</subject><ispartof>British journal of pharmacology, 2018-11, Vol.175 (21), p.4121-4136</ispartof><rights>2018 The Authors British Journal of Pharmacology published by John Wiley &amp; Sons Ltd on behalf of British Pharmacological Society.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c1527-56a21eddcfccb0af07b610c9876ea85b60f0761dc0bab3e07973b96cbb6b7f643</citedby><cites>FETCH-LOGICAL-c1527-56a21eddcfccb0af07b610c9876ea85b60f0761dc0bab3e07973b96cbb6b7f643</cites><orcidid>0000-0001-9156-0000 ; 0000-0002-0840-3619 ; 0000-0001-8303-1117</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6177617/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6177617/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,724,777,781,882,27905,27906,53772,53774</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30051456$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>de Witte, Wilhelmus E A</creatorcontrib><creatorcontrib>Versfelt, Joost W</creatorcontrib><creatorcontrib>Kuzikov, Maria</creatorcontrib><creatorcontrib>Rolland, Solene</creatorcontrib><creatorcontrib>Georgi, Victoria</creatorcontrib><creatorcontrib>Gribbon, Philip</creatorcontrib><creatorcontrib>Gul, Sheraz</creatorcontrib><creatorcontrib>Huntjens, Dymphy</creatorcontrib><creatorcontrib>van der Graaf, Piet Hein</creatorcontrib><creatorcontrib>Danhof, Meindert</creatorcontrib><creatorcontrib>Fernández-Montalván, Amaury</creatorcontrib><creatorcontrib>Witt, Gesa</creatorcontrib><creatorcontrib>de Lange, Elizabeth C M</creatorcontrib><title>In vitro and in silico analysis of the effects of D 2 receptor antagonist target binding kinetics on the cellular response to fluctuating dopamine concentrations</title><title>British journal of pharmacology</title><addtitle>Br J Pharmacol</addtitle><description>Target binding kinetics influence the time course of the drug effect (pharmacodynamics) both (i) directly, by affecting the time course of target occupancy, driven by the pharmacokinetics of the drug, competition with endogenous ligands and target turnover, and (ii) indirectly, by affecting signal transduction and homeostatic feedback. For dopamine D receptor antagonists, it has been hypothesized that fast receptor binding kinetics cause fewer side effects, because part of the dynamics of the dopaminergic system is preserved by displacement of these antagonists. Target binding kinetics of D receptor antagonists and signal transduction after dopamine and D receptor antagonist exposure were measured in vitro. These data were integrated by mechanistic modelling, taking into account competitive binding of endogenous dopamine and the antagonist, the turnover of the second messenger cAMP and negative feedback by PDE turnover. The proposed signal transduction model successfully described the cellular cAMP response for 17 D receptor antagonists with widely different binding kinetics. Simulation of the response to fluctuating dopamine concentrations revealed that a significant effect of the target binding kinetics on the dynamics of the signalling only occurs at endogenous dopamine concentration fluctuations with frequencies below 1 min . Signal transduction and feedback are important determinants of the time course of drug effects. The effect of the D receptor antagonist dissociation rate constant (k ) is limited to the maximal rate of fluctuations in dopamine signalling as determined by the dopamine k and the cAMP turnover.</description><subject>Animals</subject><subject>Binding Sites - drug effects</subject><subject>CHO Cells</subject><subject>Cricetulus</subject><subject>Dopamine - pharmacology</subject><subject>Dopamine Antagonists - pharmacology</subject><subject>Kinetics</subject><subject>Models, Biological</subject><subject>Receptors, Dopamine D2 - metabolism</subject><subject>Research Paper</subject><subject>Research Papers</subject><subject>Signal Transduction - drug effects</subject><issn>0007-1188</issn><issn>1476-5381</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNpVkc1OAyEUhYnR2Fpd-AKGrYtR6MzAdGNi6l-TJm50TYCBFqUwAaZJH8c3lbba6N3c3HvPdyA5AFxidINz3YpueYOrqiZHYIgrSoq6bPAxGCKEaIFx0wzAWYwfCOUjrU_BoESoxlk_BF8zB9cmBQ-5a6FxMBpr5HbidhNNhF7DtFRQaa1k2o0PcAyDkqpLPmRd4gvvTEww8bBQCQrjWuMW8NM4lYzMiNs5SGVtb3nIbOy8iwomD7XtZep52gKt7_gqQ1B6J5VLIa-z7hycaG6juvjpI_D-9Pg2fSnmr8-z6f28kLge06ImfIxV20otpUBcIyoIRnLSUKJ4UwuC8orgViLBRakQndBSTIgUggiqSVWOwN3et-vFSrX7H1jWBbPiYcM8N-z_xZklW_g1I5hmY5oNrvcGMvgYg9IHFiO2zYnlnNgup6y9-vvYQfkbTPkNZiaT9w</recordid><startdate>201811</startdate><enddate>201811</enddate><creator>de Witte, Wilhelmus E A</creator><creator>Versfelt, Joost W</creator><creator>Kuzikov, Maria</creator><creator>Rolland, Solene</creator><creator>Georgi, Victoria</creator><creator>Gribbon, Philip</creator><creator>Gul, Sheraz</creator><creator>Huntjens, Dymphy</creator><creator>van der Graaf, Piet Hein</creator><creator>Danhof, Meindert</creator><creator>Fernández-Montalván, Amaury</creator><creator>Witt, Gesa</creator><creator>de Lange, Elizabeth C M</creator><general>John Wiley and Sons Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-9156-0000</orcidid><orcidid>https://orcid.org/0000-0002-0840-3619</orcidid><orcidid>https://orcid.org/0000-0001-8303-1117</orcidid></search><sort><creationdate>201811</creationdate><title>In vitro and in silico analysis of the effects of D 2 receptor antagonist target binding kinetics on the cellular response to fluctuating dopamine concentrations</title><author>de Witte, Wilhelmus E A ; Versfelt, Joost W ; Kuzikov, Maria ; Rolland, Solene ; Georgi, Victoria ; Gribbon, Philip ; Gul, Sheraz ; Huntjens, Dymphy ; van der Graaf, Piet Hein ; Danhof, Meindert ; Fernández-Montalván, Amaury ; Witt, Gesa ; de Lange, Elizabeth C M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1527-56a21eddcfccb0af07b610c9876ea85b60f0761dc0bab3e07973b96cbb6b7f643</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Animals</topic><topic>Binding Sites - drug effects</topic><topic>CHO Cells</topic><topic>Cricetulus</topic><topic>Dopamine - pharmacology</topic><topic>Dopamine Antagonists - pharmacology</topic><topic>Kinetics</topic><topic>Models, Biological</topic><topic>Receptors, Dopamine D2 - metabolism</topic><topic>Research Paper</topic><topic>Research Papers</topic><topic>Signal Transduction - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>de Witte, Wilhelmus E A</creatorcontrib><creatorcontrib>Versfelt, Joost W</creatorcontrib><creatorcontrib>Kuzikov, Maria</creatorcontrib><creatorcontrib>Rolland, Solene</creatorcontrib><creatorcontrib>Georgi, Victoria</creatorcontrib><creatorcontrib>Gribbon, Philip</creatorcontrib><creatorcontrib>Gul, Sheraz</creatorcontrib><creatorcontrib>Huntjens, Dymphy</creatorcontrib><creatorcontrib>van der Graaf, Piet Hein</creatorcontrib><creatorcontrib>Danhof, Meindert</creatorcontrib><creatorcontrib>Fernández-Montalván, Amaury</creatorcontrib><creatorcontrib>Witt, Gesa</creatorcontrib><creatorcontrib>de Lange, Elizabeth C M</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>British journal of pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>de Witte, Wilhelmus E A</au><au>Versfelt, Joost W</au><au>Kuzikov, Maria</au><au>Rolland, Solene</au><au>Georgi, Victoria</au><au>Gribbon, Philip</au><au>Gul, Sheraz</au><au>Huntjens, Dymphy</au><au>van der Graaf, Piet Hein</au><au>Danhof, Meindert</au><au>Fernández-Montalván, Amaury</au><au>Witt, Gesa</au><au>de Lange, Elizabeth C M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>In vitro and in silico analysis of the effects of D 2 receptor antagonist target binding kinetics on the cellular response to fluctuating dopamine concentrations</atitle><jtitle>British journal of pharmacology</jtitle><addtitle>Br J Pharmacol</addtitle><date>2018-11</date><risdate>2018</risdate><volume>175</volume><issue>21</issue><spage>4121</spage><epage>4136</epage><pages>4121-4136</pages><issn>0007-1188</issn><eissn>1476-5381</eissn><abstract>Target binding kinetics influence the time course of the drug effect (pharmacodynamics) both (i) directly, by affecting the time course of target occupancy, driven by the pharmacokinetics of the drug, competition with endogenous ligands and target turnover, and (ii) indirectly, by affecting signal transduction and homeostatic feedback. For dopamine D receptor antagonists, it has been hypothesized that fast receptor binding kinetics cause fewer side effects, because part of the dynamics of the dopaminergic system is preserved by displacement of these antagonists. Target binding kinetics of D receptor antagonists and signal transduction after dopamine and D receptor antagonist exposure were measured in vitro. These data were integrated by mechanistic modelling, taking into account competitive binding of endogenous dopamine and the antagonist, the turnover of the second messenger cAMP and negative feedback by PDE turnover. The proposed signal transduction model successfully described the cellular cAMP response for 17 D receptor antagonists with widely different binding kinetics. Simulation of the response to fluctuating dopamine concentrations revealed that a significant effect of the target binding kinetics on the dynamics of the signalling only occurs at endogenous dopamine concentration fluctuations with frequencies below 1 min . Signal transduction and feedback are important determinants of the time course of drug effects. The effect of the D receptor antagonist dissociation rate constant (k ) is limited to the maximal rate of fluctuations in dopamine signalling as determined by the dopamine k and the cAMP turnover.</abstract><cop>England</cop><pub>John Wiley and Sons Inc</pub><pmid>30051456</pmid><doi>10.1111/bph.14456</doi><tpages>16</tpages><orcidid>https://orcid.org/0000-0001-9156-0000</orcidid><orcidid>https://orcid.org/0000-0002-0840-3619</orcidid><orcidid>https://orcid.org/0000-0001-8303-1117</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0007-1188
ispartof British journal of pharmacology, 2018-11, Vol.175 (21), p.4121-4136
issn 0007-1188
1476-5381
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6177617
source PubMed (Medline); Wiley-Blackwell Read & Publish Collection
subjects Animals
Binding Sites - drug effects
CHO Cells
Cricetulus
Dopamine - pharmacology
Dopamine Antagonists - pharmacology
Kinetics
Models, Biological
Receptors, Dopamine D2 - metabolism
Research Paper
Research Papers
Signal Transduction - drug effects
title In vitro and in silico analysis of the effects of D 2 receptor antagonist target binding kinetics on the cellular response to fluctuating dopamine concentrations
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T16%3A56%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=In%20vitro%20and%20in%20silico%20analysis%20of%20the%20effects%20of%20D%202%20receptor%20antagonist%20target%20binding%20kinetics%20on%20the%20cellular%20response%20to%20fluctuating%20dopamine%20concentrations&rft.jtitle=British%20journal%20of%20pharmacology&rft.au=de%20Witte,%20Wilhelmus%20E%20A&rft.date=2018-11&rft.volume=175&rft.issue=21&rft.spage=4121&rft.epage=4136&rft.pages=4121-4136&rft.issn=0007-1188&rft.eissn=1476-5381&rft_id=info:doi/10.1111/bph.14456&rft_dat=%3Cpubmed_cross%3E30051456%3C/pubmed_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c1527-56a21eddcfccb0af07b610c9876ea85b60f0761dc0bab3e07973b96cbb6b7f643%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/30051456&rfr_iscdi=true